Importer of Controlled Substances; Notice of Registration, 14186-14187 [2010-6412]
Download as PDF
<![CDATA[
14186
Federal Register / Vol. 75, No. 56 / Wednesday, March 24, 2010 / Notices
respond is as follows: It is estimated that
no more than 100 new respondents will
apply a year. Each application takes
approximately 20 minutes to complete.
(6) An estimate of the total public
burden (in hours) associated with the
collection is 33 hours. Total Annual
Reporting Burden: 100 × 20 minutes per
application = 2000 minutes/by 60
minutes per hour = 33 hours.
If additional information is required,
please contact, Lynn Bryant,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: March 18, 2010.
Lynn Bryant,
Department Clearance Officer, PRA, United
States Department of Justice.
[FR Doc. 2010–6441 Filed 3–23–10; 8:45 am]
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with Title 21
Code of Federal Regulations (CFR),
1301.34(a), this is notice that on January
21, 2010, Roche Diagnostics Operations
Inc., Attn: Regulatory Compliance, 9115
Hague Road, Indianapolis, Indiana
46250, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances listed in schedules I and II:
srobinson on DSKHWCL6B1PROD with NOTICES
Drug
Schedule
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .....
Alphamethadol (9605) ..................
Cocaine (9041) .............................
Ecgonine (9180) ...........................
Methadone (9250) ........................
Morphine (9300) ...........................
I
I
I
II
II
II
II
The company plans to import the
listed controlled substances for the
manufacture of diagnostic products for
distribution to its customers.
VerDate Nov<24>2008
16:24 Mar 23, 2010
Jkt 220001
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances may file comments or
objections to the issuance of the
proposed registration and may, at the
same time, file a written request for a
hearing on such application pursuant to
21 CFR 1301.43, and in such form as
prescribed by 21 CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than April 23, 2010.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: March 16, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Drug
Raw Opium (9600) .......................
Concentrate of Poppy Straw
(9670).
Schedule
II
II
The company plans to import the
listed controlled substances to
manufacture bulk active pharmaceutical
ingredients.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C 823(a) and § 952(a),
and determined that the registration of
Rhodes Technologies to import the basic
classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Rhodes
Technologies to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: March 16, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–6418 Filed 3–23–10; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2010–6411 Filed 3–23–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
Importer of Controlled Substances;
Notice of Registration
By a Notice dated June 24, 2009, and
published in the Federal Register on
July 9, 2009 (74 FR 32954) and by a
second Notice (Correction) dated August
21, 2009, and published in the Federal
Register on September 8, 2009 (74 FR
46229), Rhodes Technologies, 498
Washington Street, Coventry, Rhode
Island 02816, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in schedule
II:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
By Notice dated November 23, 2009,
and published in the Federal Register
on December 3, 2009 (74 FR 63411),
Noramco, Inc., Division of OrthoMcNeil, Inc., 500 Swedes Landing Road,
Wilmington, Delaware 19801, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
Drug
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
E:\FR\FM\24MRN1.SGM
24MRN1
Schedule
II
III
14187
Federal Register / Vol. 75, No. 56 / Wednesday, March 24, 2010 / Notices
The company plans to import the
listed controlled substances to
manufacture other controlled
substances.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Noramco Inc. to import the basic classes
of controlled substances is consistent
with the public interest, and with
United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Noramco Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: March 16, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–6412 Filed 3–23–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated December 1, 2009,
and published in the Federal Register
on December 11, 2009 (74 FR 65788),
Tocris Cookson Inc., 16144 Westwoods
Business Park, Ellisville, Missouri
63021–4500, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in
schedules I and II:
srobinson on DSKHWCL6B1PROD with NOTICES
Drug
Schedule
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
4-Bromo-2,5dimethoxyamphetamine (7391).
3,4Methylenedioxymethamphetamine (7405).
Amphetamine (1100) ....................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
VerDate Nov<24>2008
16:24 Mar 23, 2010
I
I
I
I
II
II
II
Jkt 220001
Drug
Schedule
Diprenorphine (9058) ...................
Fentanyl (9801) ............................
II
II
The company plans to import small
quantities of the above listed controlled
substances for non-clinical, laboratorybased research only.
In reference to drug code 7360
(Marihuana), the company plans to
import synthetic cannabinoid agonists.
In reference to drug code 7370
(Tetrahydrocannabinols), the company
will import a synthetic Delta-9-THC. No
other activity for these drug codes is
authorized for this registration.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Tocris Cookson Inc. to import the basic
classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Tocris
Cookson Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: March 16, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–6417 Filed 3–23–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated January 6, 2010, and
published in the Federal Register on
January 13, 2010 (75 FR 1812),
Mallinckrodt Inc., 3600 North Second
Street, St. Louis, Missouri 63147, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Drug
Phenylacetone (8501) ..................
Coca Leaves (9040) .....................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
The company plans to import the
listed controlled substances for the
manufacture of controlled substances in
bulk for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Mallinckrodt Inc. to import the basic
classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Mallinckrodt Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: March 16, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–6413 Filed 3–23–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 USC
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with Title 21
of the Code of Federal Regulations
(CFR), 1301.34(a), this is notice that on
January 22, 2010, Meridian Medical
Technologies, 2555 Hermelin Drive, St.
Louis, Missouri 63144, made
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 75, Number 56 (Wednesday, March 24, 2010)]
[Notices]
[Pages 14186-14187]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-6412]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated November 23, 2009, and published in the Federal
Register on December 3, 2009 (74 FR 63411), Noramco, Inc., Division of
Ortho-McNeil, Inc., 500 Swedes Landing Road, Wilmington, Delaware
19801, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as an importer of the basic
classes of controlled substances listed in schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Opium, raw (9600).......................... II
Poppy Straw Concentrate (9670)............. III
------------------------------------------------------------------------
[[Page 14187]]
The company plans to import the listed controlled substances to
manufacture other controlled substances.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the
registration of Noramco Inc. to import the basic classes of controlled
substances is consistent with the public interest, and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Noramco Inc. to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above
named company is granted registration as an importer of the basic
classes of controlled substances listed.
Dated: March 16, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-6412 Filed 3-23-10; 8:45 am]
BILLING CODE 4410-09-P
